- The Hippo Signaling Pathway in Drug Resistance in Cancer
Renya Zeng et al, 2021, Cancers CrossRef - A brief review: some compounds targeting YAP against malignancies
Zhenxue Tang et al, 2019, Future Oncology CrossRef - In silico exploration of anti-prostate cancer compounds from differential expressed genes
Basiru Olaitan Ajiboye et al, 2024, BMC Urology CrossRef - Introducing, OncoTarget
Mikhail Blagosklonny et al, 2010, Oncotarget CrossRef - Molecular insights of Hippo signaling in the chick developing lung
Violina Baranauskaite Barbosa et al, 2023, Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms CrossRef - In Vitro Anticancer Activity of Imperata cylindrica Root’s Extract toward Human Cervical Cancer and Identification of Potential Bioactive Compounds
Paul Nayim et al, 2021, BioMed Research International CrossRef - Positive Inotropic Agents in Cancer Therapy: Exploring Potential Anti-Tumor Effects
Eduarda Ribeiro et al, 2024, Targets CrossRef - A drug repurposing screening reveals a novel epigenetic activity of hydroxychloroquine
Raffaella Catalano et al, 2019, European Journal of Medicinal Chemistry CrossRef - Sympathetic β1-adrenergic signaling contributes to regulation of human bone metabolism
Sundeep Khosla et al, 2018, Journal of Clinical Investigation CrossRef - Deciphering Potential Role of Hippo Signaling Pathway in Breast Cancer: A Comprehensive Review
Hunayna Bhavnagari et al, 2023, Current Pharmaceutical Design CrossRef - MT2-MMP is differentially expressed in multiple myeloma cells and mediates their growth and progression
Shohreh Fakhari et al, 2022, Cellular Signalling CrossRef - Antitumor effect of dobutamine on multiple myeloma via mitogen-activated protein kinase pathwayin vitro
Bingqian Xie et al, 2016, Acta Biochimica et Biophysica Sinica CrossRef - Designing new generation of potent inhibitors against membrane-type matrix metalloproteinase-2: a computational effort against multiple myeloma
Shohreh Fakhari et al, 2020, Journal of Biomolecular Structure and Dynamics CrossRef - Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing
Min Shen et al, 2018, Oncotarget CrossRef